FOR IN VITRO RESEARCH & LABORATORY USE ONLYNOT FOR HUMAN OR VETERINARY USECASH ON DELIVERY AVAILABLEFOR IN VITRO RESEARCH & LABORATORY USE ONLYNOT FOR HUMAN OR VETERINARY USECASH ON DELIVERY AVAILABLE
Follistatin 344 by Enhanced Pharma - 1mg × 1 vial
Have questions?Get instant help from our team
RESEARCH PEPTIDE / Enhanced Pharma

Follistatin 344 (FS-344) - Enhanced Pharma - 1mg × 1 vial

Buy Follistatin 344 1mg in India - Enhanced Pharma Research Grade

Follistatin 344 - Myostatin Inhibitor

→ View Follistatin 344 buying guide for India

Naturally occurring glycoprotein that binds and neutralizes myostatin and activin A. Studied for muscle hypertrophy via TGF-β superfamily blockade. WADA prohibited since 2019.

In Stock
HPLC Tested
High Purity
Made in USA
Pan-India Delivery

Order this product

Sealed Box
₹10,800
BAC Water incl.

Factory-sealed box: 1mg × 1 vial. Ready for immediate dispatch.

🚚 Pan-India delivery  /  Cash on Delivery available

Why Enhanced Pharma for Follistatin 344?

Enhanced Pharma, the Follistatin 344 option

US-sourced single vials, broad GH-axis and metabolic catalog.

  • Single-vial format lets you test a compound without committing to a full sealed box, useful for short pilot protocols.
  • Catalog skews toward GH-axis, metabolic and cognitive research peptides with higher per-vial concentrations.
  • Best fit for researchers who run short pilot protocols or want a higher-concentration vial for fewer injections.

Comparing brands? See all Follistatin 344 listings on the Follistatin 344 in India hub, or browse our full peptide catalog in India.

Why researchers reach for Follistatin 344

Myostatin neutralization

Binds myostatin (GDF-8), preventing its suppression of muscle growth - the rationale behind follistatin's anabolic research interest.

Activin A blockade

Also neutralizes activin A - broader TGF-β superfamily antagonism beyond myostatin alone.

Satellite cell activation

Removing myostatin's suppressive signal allows satellite-cell-driven muscle expansion in animal models.

Strong gene-therapy precedent

Primate and human gene-therapy studies for muscular dystrophy demonstrated significant muscle hypertrophy and strength gains - proof-of-concept for the pathway.

Community Insights

Self-reported by pep-pedia.org users and published research summaries. Not clinical evidence.

68%
Effectiveness
of 96 respondents
62%
Would Recommend
of 128 respondents
Side effects Injection site reaction Limited human safety data WADA prohibited
Best results 10–30 days

How Follistatin 344 Works

01

Myostatin and activin A binding

Follistatin's extracellular domains bind myostatin and activin A with high affinity, preventing them from reaching their receptors.

02

ActRIIB pathway blockade

With ligands sequestered, the ActRIIB receptor on muscle cells goes unactivated - TGF-β-driven muscle-growth suppression is removed.

03

Hypertrophy permission

Released from myostatin's constraint, muscle satellite cells and existing fibres can expand more freely under anabolic stimuli - the mechanism behind follistatin's research interest.

Mechanism summary sourced from pep-pedia.org and the published peptide research literature.

Stack It With

Full Specifications
Peptide
Follistatin 344
Brand
Enhanced Pharma
Sequence
344-amino-acid precursor (cleaved to 315-aa circulating form); full sequence UniProt P19883
Molecular Weight
~37,800 Da (FS-315 mature form)
CAS Number
80449-31-6
Half-Life
~90 minutes (short)
Typical Dose
100–200 mcg (anecdotal protocols only)
Cycle Duration
10–30 days (anecdotal)
Dosage
1mg per vial
Quantity
1 vial / box
Form
Lyophilized powder
Storage
−20°C lyophilized; 2–8°C reconstituted
Reconstitution
BAC water (bacteriostatic) - included
Intended Use
Research use only - not for human consumption

Frequently Asked Questions

How is FS-344 different from FS-315 and FS-288?

FS-344 is the precursor that gets cleaved into the circulating FS-315 form (with a C-terminal acidic tail) or FS-288 (without). FS-315 has lower cell-surface binding and longer plasma residence; FS-288 binds cell surfaces more avidly.

Is the data mostly gene-therapy?

Yes. Pep-pedia notes most clinical follistatin research has used gene delivery (AAV vectors), not exogenous peptide injection. Injectable peptide use has limited human data and a short ~90-minute half-life that constrains dosing.

WADA status?

Follistatin has been on the WADA prohibited list since 2019. It will cause failed drug tests in athletes; use is strictly for laboratory research.

Why such a short cycle?

Pep-pedia's anecdotal protocol cycles run 10–30 days - driven by the short half-life requiring frequent dosing and limited human safety data for prolonged exposure.

Storage requirements?

Strict refrigeration. Lyophilized vials at −20°C; reconstituted vials at 2–8°C. The glycoprotein structure is more thermolabile than smaller peptides - keep cold throughout the research window.

Ready to order

Follistatin 344 - Enhanced Pharma

₹10,800 · 1mg × 1 vial · Lyophilized powder + BAC water · Pan-India delivery

Add to Cart

Research Use Only

This product is intended solely for laboratory and research purposes. It is not intended for human consumption, therapeutic use, or as a food or drug product. By purchasing, you confirm that this product will be used exclusively for legitimate research applications.

Read all customer reviews →